Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model

Josep C Jimenez-Chillaron1, Marcelino Hernandez-Valencia, Carolyn Reamer

  • 1Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA.

Diabetes
|March 1, 2005
PubMed

Insights

Low birth weight (LBW) offspring develop glucose intolerance due to impaired insulin secretion. This study reveals primary beta-cell dysfunction in LBW mice, offering insights into type 2 diabetes development.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Developmental Biology

Background:

  • Low birth weight (LBW) is a significant risk factor for developing type 2 diabetes later in life.
  • Understanding the early metabolic defects linking LBW to diabetes is crucial for prevention and intervention.

Purpose of the Study:

  • To investigate the early metabolic alterations in offspring from a mouse model of pregnancy-induced undernutrition and LBW.
  • To identify the specific defects responsible for the glucose intolerance observed in LBW mice.

Main Methods:

  • Developed a mouse model by restricting maternal food intake during late gestation to induce LBW.
  • Assessed glucose metabolism, insulin sensitivity, insulin secretion, and beta-cell function in young adult LBW offspring (2 months old).
  • Analyzed insulin levels, insulin tolerance tests, glucose disposal, glucose uptake in tissues, and islet cell function.

Main Results:

  • LBW offspring exhibited normal birth weight post-normalization but developed severe glucose intolerance by 6 months.
  • At 2 months, LBW mice showed elevated fasting insulin levels but normal insulin sensitivity.
  • Islets from LBW mice displayed basal hyperinsulin secretion, lack of glucose responsiveness, and increased hexokinase activity, despite normal beta-cell mass.

Conclusions:

  • Primary beta-cell dysfunction, characterized by dysregulated insulin secretion, is a key factor in the pathogenesis of LBW-associated type 2 diabetes in this mouse model.
  • These findings highlight the critical role of early-life nutrition and beta-cell function in long-term metabolic health.
  • The study provides a valuable model for further research into the mechanisms connecting LBW to diabetes.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...